Patients in LCT group had a numerically longer survival than that of non-LCT group, but the improvement did not reach statistical significance in this study.
← all excerpts
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
1
—
—